https://www.live-feeds.com/feed/psychedelics-stock-up-190-this-year-flies-high-againContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/psychedelics-stock-up-190-this-year-flies-high-againhttps://www.live-feeds.com/feed/psychedelics-stock-up-190-this-year-flies-high-again#u69994Wed, 16 Sep 2026 08:10:10 +0000Definium Therapeutics announced positive topline results from the Phase 3 Panorama study of its LSD-based anxiety and depression drug, DT120 ODT. The therapy eased anxiety in a large trial, marking another successful outcome for the treatment. This latest trial win pushes the company closer toward a Food and Drug Administration submission for the anxiety drug. Following the positive trial news, the psychedelics stock surged again, adding to a substantial gain recorded over the course of the year. Investors and market watchers are closely tracking the regulatory progress of the treatment as cli